POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No21/2015
Date of issue:2015-02-26
Short name of the issuer
SOPHARMA AD
Subject
NOTIFICATION 26022015
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors hereby notifies that the transformation through merger of Bulgarian Rose – Sevtopolis AD in Sopharma AD has been registered with the Commercial Register with number 20150226134200. The registered capital of Sopharma AD is 134 797 899 BGN. Sopharma AD is now undertaking all necessary actions for registration of the new issuance of 2 797 899 shares, with nominal value of 1.00 BGN with the Central Depository AD.
Annexes
FileDescription
NOTIFICATION 26022015.docNOTIFICATION 26022015
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2015-02-26Ognian DonevExecutive director